Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.3269
+0.0258 (8.57%)
At close: May 12, 2025, 4:00 PM
0.3250
-0.0019 (-0.58%)
After-hours: May 12, 2025, 7:59 PM EDT
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $20.26 million as of May 12, 2025. Its market cap has decreased by -73.90% in one year.
Market Cap
20.26M
Enterprise Value
4.30M
1-Year Change
-73.90%
Ranking
Category
Stock Price
$0.33
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $20.26M, a decrease of -92.10%. That is a compound annual growth rate of -50.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 18.66M | -35.96% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |